FDA Guidance
- May 10, 2022
-
FDA Guidance
FDA Limits Use of J&J Vaccine Limitation is due to the J&J vaccine's link to rare but serious blood clots; mRNA vaccines are recommended instead.
- Read More
- February 8, 2022
-
FDA Guidance
Moderna’s COVID-19 Vaccine for 18+ Officially Approved by FDA and CDC The vaccine is no longer under Emergency Use Authorization for 18+.
- Read More
- October 19, 2021
-
FDA Guidance
Additional Vaccine Boosters Moving Through Authorization Process FDA also in early stages of reviewing oral antiviral treatments for COVID-19.
- Read More
- September 21, 2021
-
FDA Guidance
Pfizer Vaccine Boosters Expected Soon; Updated Vaccine Wastage Guidance Issued Boosters recommended for those age 65+, health care workers, and those at high risk for COVID-19.
- Read More
- July 19, 2021
-
FDA Guidance
FDA Announces Revisions to EUA Fact Sheets for Janssen/Johnson & Johnson Vaccine Fact sheets now include information regarding an observed increased risk of Guillain-Barré syndrome.
- Read More